Biotech Acquisition (BIOT) Stock Price, News & Analysis

Company Overview

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Key Stats

• Today's Range: $10.14 to $10.19
• 50-Day Range: $10.08 to $10.32
• 52-Week Range: $8.30 to $10.41
• Volume: 44,400 shs
• Average Volume: 244,605 shs
• Market Capitalization: $291.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BIOT Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Biotech Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotech Acquisition investors own include (AOL) (AOL), CNX Resources (CNX), Southwest Airlines (LUV), Meta Platforms (META), Tesla (TSLA), Finance of America Companies (FOA) and Equifax (EFX).

Company Calendar

• Today: 5/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:BIOT
• CIK: 1825413
• Web: bioacq.com
• Phone: 212-227-1905
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-6,860,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -42.22%
• Return on Assets: 3.48%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.03
• Quick Ratio: 0.03

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.95) per share
• Price / Book: -10.68

Miscellaneous

• Outstanding Shares: 28,750,000
• Free Float: 23,288,000
• Market Cap: $291.81 million
• Optionable: Not Optionable
• Beta: -0.12